Table 1.
Donor features corresponding to the CAF cell lines used in this study
Donors | Age (years) | Sex | Tumourtype | T-size (mm) | T-stage |
---|---|---|---|---|---|
1 | 71 | M | BAA | 20 | 1a |
2 | 72 | F | BAA | 16 | 1a |
3 | 70 | M | AC | 23 | 1b |
4 | 72 | F | SCC | 32 | 2b |
5 | 63 | M | AC | 30 | 1b |
6 | 78 | M | AC | 38 | 2b |
7 | 78 | M | SCC | 20 | 1a |
8 | 48 | F | AC | 13 | 1a |
9 | 69 | F | AC | 30 | 1b |
10 | 73 | M | SCC | 18 | 1a |
11 | 64 | F | AC | 8 | 1a |
12 | 50 | M | LCC | 50 | 2a |
13 | 64 | M | AC | 7 | 1a |
14 | 51 | M | AC | 60 | 2a |
15 | 72 | F | SCC | 40 | 2a |
16 | 73 | M | AC | 11 | 1a |
Abbreviations: BAA = bronchio alveolar adenocarcinoma; AC = adenocarcinoma
SCC = Squamous cell carcinoma; LCC = Large cell carcinoma; M = male; F = female